Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125303491 | 12530349 | 1 | I | 20160625 | 20160706 | 20160706 | EXP | ES-NOVEL LABORATORIES, INC-2016-02961 | NOVEL LABS | SOLER-PALACIN P, FRICK M, BOIX H, MARTIN-GOMEZ M, RODRIGO-PENDAS J, LONGUEIRA F. PRIMARY CUTANEOUS ASPERGILLOSIS IN A PRETERM INFANT. PEDIATR-INFECT-DIS-J. 2016;35(6):704-706. | 0.00 | M | Y | 0.00000 | 20160706 | MD | ES | ES |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125303491 | 12530349 | 1 | PS | VORICONAZOLE. | VORICONAZOLE | 1 | Intravenous (not otherwise specified) | UNKNOWN | 207371 | 3 | MG/KG | Q12H | |||||||
125303491 | 12530349 | 2 | SS | Vancomycin | VANCOMYCIN | 1 | Unknown | UNKNOWN | 90439 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125303491 | 12530349 | 1 | Aspergillus infection |
125303491 | 12530349 | 2 | Aspergillus infection |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125303491 | 12530349 | HO |
125303491 | 12530349 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125303491 | 12530349 | Hepatotoxicity | |
125303491 | 12530349 | Multiple organ dysfunction syndrome | |
125303491 | 12530349 | Renal impairment | |
125303491 | 12530349 | Shock |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |